Melanie Hansen

Melanie Hansen currently serves as Executive Director, Corporate Controller at Madrigal Pharmaceuticals, having joined in September 2023. Prior to this role, Melanie was the Senior Director, Controller, and Corporate Controller at AVEO Oncology from May 2021 to March 2023, contributing significantly to the company during its acquisition by LG Chem. Melanie's extensive experience spans various finance and accounting roles within the biopharmaceutical and healthcare sectors, including Associate Director of Finance at Zealand Pharma and Interim Corporate Controller at Valeritas, where success was achieved in leading the finance department through an acquisition. Earlier career positions include accounting roles at Fortress Biotech and Athena Health Care Systems, with foundational experiences gained as a Staff Accountant at Scott A. Goffstein & Associates, LLP. Melanie holds a Bachelor of Science degree in Business Administration with an Accounting concentration from Fitchburg State University.